M. S. . Rahman, M. R. . Karim, and M. A. Haque, “Efficacy of Rifaximin in Diarrhoea Predominant Irritable Bowel Syndrome: A Placebo Controlled Clinical Trial”, Med. Today, vol. 35, no. 1, pp. 44–48, Apr. 2023.